Management of Ornithine Transcarbamylase Deficiency in Pregnancy

 

 Buy Article Permissions and Reprints

ABSTRACT

Ornithine transcarbamylase (OTC) deficiency is the most common enzymatic deficiency in the urea cycle. In catabolic states, such as the intrapartum and immediate postpartum periods, hyperammonemic comas with permanent neurological damage and death can develop. We report six cases of OTC deficiency during pregnancy managed at our institution and review the literature on OTC deficiency during pregnancy. Using the patient database from our Metabolic Clinic, pregnant OTC deficiency carriers were identified. The antenatal, intrapartum, and postpartum periods were analyzed. Corresponding literature was reviewed and an extensive multidisciplinary management plan developed. All six pregnant women had favorable outcomes. No hyperammonemic episodes occurred, and intensive care unit admissions and hemodialysis were not required. Although risk to women with OTC deficiency during the intra- and postpartum period exists, multidisciplinary management and a coherent plan usually result in successful labor, delivery, and postpartum. A comprehensive plan for patients who develop hyperammonemia is recommended.

REFERENCES

• 1 Brusilow S, Horwich A. Urea cycle enzymes. In: Scriver C, Sly W, Valle D, Childs B, Kinzler K, Vogelstein B The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York; McGraw-Hill 2000: 1909-1963
  PubMedGoogle Scholar
• 2 Rowe P C, Newman S L, Brusilow S W. Natural history of symptomatic partial ornithine transcarbamylase deficiency.  N Engl J Med. 1986;  314 541-547
  CrossrefPubMedGoogle Scholar
• 3 Arn P H, Hauser E R, Thomas G H, Herman G, Hess D, Brusilow S W. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma.  N Engl J Med. 1990;  322 1652-1655
  CrossrefPubMedGoogle Scholar
• 4 Legras A, Labarthe F, Maillot F, Garrigue M-A, Kouatchet A, Ogier de Baulny H. Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations.  Crit Care Med. 2002;  30 241-244
  CrossrefPubMedGoogle Scholar
• 5 Batshaw M L, Roan Y, Jung A L, Rosenberg L A, Brusilow S W. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.  N Engl J Med. 1980;  302 482-485
  CrossrefPubMedGoogle Scholar
• 6 Peterson D E. Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency.  Obstet Gynecol. 2003;  102(5 Pt 2) 1212-1215
  CrossrefPubMedGoogle Scholar
• 7 Schimanski U, Krieger D, Horn M, Stremmel W, Wermuth B, Theilmann L. A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy.  Hepatology. 1996;  24 1413-1415
  CrossrefPubMedGoogle Scholar
• 8 Redonnet-Vernhet I, Rouanet F, Pedespan J M, Hocke C, Parrot F. A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrate.  Neurology. 2000;  54 1008
  PubMedGoogle Scholar
• 9 Cordero D R, Baker J, Dorinzi D, Toffle R. Ornithine transcarbamylase deficiency in pregnancy.  J Inherit Metab Dis. 2005;  28 237-240
  CrossrefPubMedGoogle Scholar
• 10 Verlinsky Y, Rechitsky S, Verlinsky O, Strom C, Kuliev A. Preimplantation diagnosis for ornithine transcarbamylase deficiency.  Reprod Biomed Online. 2000;  1 45-47
  CrossrefPubMedGoogle Scholar
• 11 Enns G M, Berry S A, Berry G T, Rhead W J, Brusilow S W, Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.  N Engl J Med. 2007;  356 2282-2292
  CrossrefPubMedGoogle Scholar
• 12 Lee B, Goss J. Long-term correction of urea cycle disorders.  J Pediatr. 2001;  138(1 Suppl) S62-S71
  CrossrefPubMedGoogle Scholar
• 13 Berry G T, Steiner R D. Long-term management of patients with urea cycle disorders.  J Pediatr. 2001;  138(1 Suppl) S56-S60 discussion S60-S61
  CrossrefPubMedGoogle Scholar
• 14 Wilcken B. Problems in the management of urea cycle disorders.  Mol Genet Metab. 2004;  81(Suppl 1) S86-S91
  PubMedGoogle Scholar

Ignatia B Van den VeyverM.D. 

Department of Obstetrics and Gynecology, Baylor College of Medicine

1709 Dryden Suite 1100, MS BCM610 Houston, TX 77030

Email: iveyver@bcm.edu